Robert LeBoyer

Stock Analyst at Noble Capital Markets

(0.99)
# 2186
Out of 5,383 analysts
20
Total ratings
Success rate
Average return
16 Stocks
Name Action PT Current % Upside Ratings Updated
TNXP Tonix Pharmaceutical...
Reiterates: Outperform
70 70
35.47 97.35% 2 Mar 20, 2025
NTRB Nutriband
Initiates Coverage On: Outperform
13
7.87 65.18% 1 Jan 22, 2025
GOVX Geovax Labs
Maintains: Outperform
6 10
0.94 963.83% 2 Aug 19, 2024
UNCY Unicycive Therapeuti...
Initiates Coverage On: Outperform
60
5.99 901.67% 1 Feb 14, 2024
CVKD Cadrenal Therapeutic...
Initiates Coverage On: Outperform
60
10.35 479.71% 1 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
2.77 261.01% 1 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
1.74 704.6% 1 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Sep 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
150
n/a n/a 1 Oct 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
8
0.96 733.33% 2 Aug 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
120
n/a n/a 1 Jan 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Oct 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
9.57 25.39% 1 Sep 28, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
825000
n/a n/a 1 Aug 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 10, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
15
3.61 315.51% 2 Mar 8, 2018